The 10th Annual Health Technology Assessment (HTA) Conference, held on 30 September 2025 in Athens, Greece, brought together leading experts, policymakers, and over 150 participants from Greece and across Europe. With the EU HTA Regulation in force since January 2025, the conference focused on its strategic implications, serving as a key platform for discussion on future evidence-based, inclusive, and patient-centred health policies at both national and European levels.
The EU4MEDTECH project was presented at the conference, bringing its work into the spotlight of Europe’s HTA community. Ružica Bandić, DMD, from the University of Split School of Medicine, delivered a presentation titled “Methodologies Mapping for Generation and Evaluation of Clinical Evidence for High-Risk and Innovative Medical Devices and In Vitro Diagnostics (IVDs)”.
Her presentation explored how clinical evidence is currently generated and assessed for advanced medical technologies, drawing on findings from EU4MEDTECH’s ongoing literature review and stakeholder mapping across several European countries. It highlighted key challenges in existing evaluation practices, identified methodological gaps in clinical evidence generation, and underlined the growing need for more harmonised approaches across national HTA systems, particularly for high-risk and innovative medical devices and IVDs, where fragmented methodologies can slow down assessment and adoption.
As EU4MEDTECH progresses, the insights shared at the conference will directly inform the development of practical tools and frameworks co-created with stakeholders across Europe, supporting more robust, transparent, and aligned clinical evidence evaluation.
